177 related articles for article (PubMed ID: 26268327)
1. Levetiracetam might act as an efficacious drug to attenuate cognitive deficits of Alzheimer's disease.
Xiao R
Curr Top Med Chem; 2016; 16(5):565-73. PubMed ID: 26268327
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model.
Sanchez PE; Zhu L; Verret L; Vossel KA; Orr AG; Cirrito JR; Devidze N; Ho K; Yu GQ; Palop JJ; Mucke L
Proc Natl Acad Sci U S A; 2012 Oct; 109(42):E2895-903. PubMed ID: 22869752
[TBL] [Abstract][Full Text] [Related]
3. A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam.
Stockburger C; Miano D; Baeumlisberger M; Pallas T; Arrey TN; Karas M; Friedland K; Müller WE
J Alzheimers Dis; 2016; 50(1):201-15. PubMed ID: 26639968
[TBL] [Abstract][Full Text] [Related]
4. Effects of levetiracetam, an antiepileptic drug, on memory impairments associated with aging and Alzheimer's disease in mice.
Devi L; Ohno M
Neurobiol Learn Mem; 2013 May; 102():7-11. PubMed ID: 23416036
[TBL] [Abstract][Full Text] [Related]
5. Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease.
Cumbo E; Ligori LD
Epilepsy Behav; 2010 Apr; 17(4):461-6. PubMed ID: 20188634
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam: a practical option for seizure management in elderly patients with cognitive impairment.
Lippa CF; Rosso A; Hepler M; Jenssen S; Pillai J; Irwin D
Am J Alzheimers Dis Other Demen; 2010 Mar; 25(2):149-54. PubMed ID: 19001351
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study.
Belcastro V; Costa C; Galletti F; Pisani F; Calabresi P; Parnetti L
Eur J Neurol; 2007 Oct; 14(10):1176-8. PubMed ID: 17880574
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam improves verbal memory in high-grade glioma patients.
de Groot M; Douw L; Sizoo EM; Bosma I; Froklage FE; Heimans JJ; Postma TJ; Klein M; Reijneveld JC
Neuro Oncol; 2013 Feb; 15(2):216-23. PubMed ID: 23233537
[TBL] [Abstract][Full Text] [Related]
9. Treatment of epilepsy for people with Alzheimer's disease.
Liu J; Wang LN; Wu LY; Wang YP
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011922. PubMed ID: 27805721
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam Alters Oscillatory Connectivity in Alzheimer's Disease.
Musaeus CS; Shafi MM; Santarnecchi E; Herman ST; Press DZ
J Alzheimers Dis; 2017; 58(4):1065-1076. PubMed ID: 28527204
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.
Chaisewikul R; Privitera MD; Hutton JL; Marson AG
Cochrane Database Syst Rev; 2001; (1):CD001901. PubMed ID: 11279737
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam for agitated Alzheimer's disease patients.
Weiner MF; Womack KB; Martin-Cook K; Svetlik DA; Hynan LS
Int Psychogeriatr; 2005 Jun; 17(2):327-8. PubMed ID: 16050441
[No Abstract] [Full Text] [Related]
13. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
Klitgaard H; Matagne A; Gobert J; Wülfert E
Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
[TBL] [Abstract][Full Text] [Related]
14. Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies.
Sola I; Aso E; Frattini D; López-González I; Espargaró A; Sabaté R; Di Pietro O; Luque FJ; Clos MV; Ferrer I; Muñoz-Torrero D
J Med Chem; 2015 Aug; 58(15):6018-32. PubMed ID: 26181606
[TBL] [Abstract][Full Text] [Related]
15. Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance.
Bakker A; Albert MS; Krauss G; Speck CL; Gallagher M
Neuroimage Clin; 2015; 7():688-98. PubMed ID: 25844322
[TBL] [Abstract][Full Text] [Related]
16. Seizures in patients with glioma treated with phenytoin and levetiracetam.
Merrell RT; Anderson SK; Meyer FB; Lachance DH
J Neurosurg; 2010 Dec; 113(6):1176-81. PubMed ID: 20560728
[TBL] [Abstract][Full Text] [Related]
17. An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study.
Sen A; Akinola M; Tai XY; Symmonds M; Davis Jones G; Mura S; Galloway J; Hallam A; Chan JYC; Koychev I; Butler C; Geddes J; Van Der Putt R; Thompson S; Manohar SG; Frangou E; Love S; McShane R; Husain M
Trials; 2021 Jul; 22(1):508. PubMed ID: 34332638
[TBL] [Abstract][Full Text] [Related]
18. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment.
Bakker A; Krauss GL; Albert MS; Speck CL; Jones LR; Stark CE; Yassa MA; Bassett SS; Shelton AL; Gallagher M
Neuron; 2012 May; 74(3):467-74. PubMed ID: 22578498
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer's type.
Kyomen HH; Whitfield TH; Baldessarini RJ
J Clin Psychopharmacol; 2007 Aug; 27(4):408-10. PubMed ID: 17632234
[No Abstract] [Full Text] [Related]
20. Piracetam for dementia or cognitive impairment.
Flicker L; Grimley Evans J
Cochrane Database Syst Rev; 2000; (2):CD001011. PubMed ID: 10796585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
